Skip to content

12-Panel TCA, MDMA & Buprenorphine Rapid Drug Test Cup – 120 mL | AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, TCA & THC

In Stock

$6.99$2.95/each

Buy More, Save More
Quantity
1

Description

12 DRUG PANELS • TCA, OXY & BUP • 102 mL

12-Panel TCA, Oxycodone & Buprenorphine Rapid Drug Test Cup

Comprehensive preliminary urine drug screening with dedicated TCA, oxycodone and buprenorphine panels.

This self-contained urine drug test cup screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone, tricyclic antidepressants and marijuana.

Collection, temperature verification and twelve-panel screening take place in one convenient device. The leak-resistant design and peel-to-read test display support secure handling and preliminary results in approximately five minutes.

Product Highlights

Twelve-Drug Screening Screens for AMP/1000, OPI/300, MET/1000, BZO/300, COC/300, MTD/300, OXY/100, BUP/10, MDMA/500, THC/50, BAR/300, TCA/1000
Dedicated TCA Panel Screens for tricyclic antidepressants at the manufacturer-listed 1,000 ng/mL cutoff.
Dedicated Oxycodone Panel Includes separate oxycodone screening at the listed 100 ng/mL cutoff.
Buprenorphine Screening Includes a dedicated BUP panel at the listed 10 ng/mL cutoff.
Expanded Opioid Coverage Includes separate BUP, MTD, OPI and OXY panels.
Results in 5 Minutes Provides easy-to-read preliminary results for efficient onsite screening.
Self-Contained Testing Collection and preliminary screening are completed without separate test equipment.
102 mL Capacity Provides practical specimen capacity for convenient urine collection.
Leak-Resistant Design Secure lid helps reduce spills, leakage and accidental opening.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
Manufacturer-Stated Accuracy Manufacturer-provided information reports up to 99% accuracy when used as directed.
Same-Day Shipping Eligible orders placed within the applicable processing window ship the same business day.
Twelve Drug Panels with TCA, Oxycodone, Buprenorphine and OPI/300 Screening A broad preliminary screening solution for healthcare facilities, occupational health clinics, treatment programs, rehabilitation centers, collection sites and authorized workplace testing.

Drug Panels and Cutoff Levels

Review the twelve drug categories and manufacturer-listed preliminary screening cutoff levels.

TEST STRIP TESTED DRUG ESTIMATED DETECTION TIME / CUTOFF
AMP   AMP   AMP   AMP
 Amphetamines 1–2 Days • 1,000 ng/mL
BAR   BAR   BAR   BAR
 Barbiturates 1–4 Days • 300 ng/mL
BUP   BUP   BUP   BUP
 Buprenorphine 2–6 Days • 10 ng/mL
BZO   BZO   BZO   BZO
 Benzodiazepines 1–2 Days • 300 ng/mL
COC   COC   COC   COC
 Cocaine 2–4 Days • 300 ng/mL
MDMA   MDMA   MDMA
 MDMA / Ecstasy 2–4 Days • 500 ng/mL
MET   MET   MET   MET
 Methamphetamine 2–4 Days • 1,000 ng/mL
MTD   MTD   MTD   MTD
 Methadone 1–3 Days • 300 ng/mL
OPI   OPI   OPI   OPI
 Morphine / Opiates 2–3 Days • 300 ng/mL
OXY   OXY   OXY   OXY
 Oxycodone 1–3 Days • 100 ng/mL
TCA   TCA   TCA   TCA
 Tricyclic Antidepressants 2–7 Days • 1,000 ng/mL
THC   THC   THC   THC
 Marijuana 15–30 Days • 50 ng/mL
Please Note: Detection windows vary according to dosage, frequency of use, metabolism, hydration, body composition, specimen concentration and other individual factors. Refer to the manufacturer’s package insert for exact cutoff levels, cross-reactivity and interpretation requirements.
Dedicated TCA Screening The TCA panel provides preliminary class-based screening for tricyclic antidepressants at the listed 1,000 ng/mL cutoff. It does not identify a particular medication or measure the amount present.
Separate BUP, MTD, OPI and OXY Panels Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Separate strips provide targeted preliminary screening for each listed analyte.
Understanding a Cutoff Level A cutoff is the concentration used to classify a preliminary result. A presumptive positive indicates that the test response met or exceeded the assay threshold; it does not measure the exact drug concentration.

How to Use the 12-Panel TCA, MDMA & Buprenorphine Rapid Drug Test Cup

Understanding the 12-Panel TCA, MDMA & Buprenorphine Rapid Drug Test Cup Results

Product Dimensions and Specifications

12-Panel TCA, Oxycodone & Buprenorphine Rapid Drug Test Cup
Drug panels AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, TCA and THC
Buprenorphine cutoff BUP/10
MDMA cutoff MDMA/500
Methamphetamine cutoff MET/1000
Opiate cutoff OPI/300
Oxycodone cutoff OXY/100
TCA cutoff TCA/1000
Result time Approximately 5 minutes
Capacity 102 mL
Height 3.25 inches
Bottom width 2 inches
Lid width 2.63 inches
Approximate weight 0.18 lb

Manufacturer-Reported Regulatory Status

According to manufacturer-provided information, this exact configuration is CLIA Waived and FDA 510(k) Cleared. Verify the exact package labeling, intended use and individual assay status before advertising, purchasing or use.

What CLIA Waived Means Eligible point-of-care sites may use a waived test under a CLIA Certificate of Waiver when the manufacturer’s instructions and applicable federal, state and local requirements are followed.
What FDA 510(k) Cleared Means FDA 510(k) clearance means the device was found substantially equivalent to a legally marketed predicate for its labeled intended use.

Depending on its exact labeling and applicable requirements, this cup may be suitable for physician offices, healthcare facilities, occupational health clinics, treatment and rehabilitation programs, drug-testing collection sites and qualifying workplace-screening programs.

Use Notice: Do not advertise this product for unrestricted over-the-counter or home use unless the exact FDA-cleared labeling specifically permits that use. FDA clearance and CLIA-waived status are separate designations.

Frequently Asked Questions

1. Which substances does this 12-panel cup screen for? It screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone, tricyclic antidepressants and marijuana.
2. What does the TCA panel detect? It provides preliminary class-based screening for tricyclic antidepressants at the manufacturer-listed 1,000 ng/mL cutoff.
3. Why are BUP, MTD, OPI and OXY tested separately? Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated strips provide targeted preliminary screening.
4. How quickly are results available? Preliminary results are available in approximately five minutes. Results should not be interpreted after eight minutes or outside the package insert’s stated reading window.
5. Does the temperature strip prove specimen authenticity? No. It measures specimen temperature shortly after collection and helps identify samples outside the expected range. It does not independently prove authenticity or detect every form of tampering.
6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, treatment or legal decisions are made.
Twelve Drug Panels. TCA, Oxycodone and Buprenorphine Screening. One Convenient Cup. Simplify preliminary urine drug screening with a self-contained cup designed for broad panel coverage, secure specimen collection and easy visual interpretation.
Order 12-Panel Drug Test Cups Today

Shipping & Delivery

  • All orders will be shipped the same day if placed before 3:00 PM EST.
  • Next-day shipments will not be delivered on weekends, and the time taken on air shipments should be counted as business days.

Why order from us

  • CLIA-waived screening supplies for qualified lab and point-of-care workflows.
  • Same-day shipping on orders placed before 3:00 PM EST.
  • Volume and bulk pricing available — contact us for recurring supply.